Europe to test the feasibility of new ASF vaccine


A new project to develop the next-generation ASF vaccine has been launched by Hipra, with support from the EU’s Horizon Europe program. The VAX4ASF program is an innovation from previous approaches. The goal is to provide a definitive, effective, and safe solution against the ASF virus.

The proj...

Sign in  as a member, or Join our Community  for free to unlock the full article.